Gabapentin Capsule
Product Images NDC 72789-289

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 72789-289). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (72789289)

Gabapentin USP 100 mg capsules packaging label from PD-Rx Pharmaceuticals, Inc. The label indicates 30 capsules per bottle with NDC 72789-289-30. It includes warnings about drowsiness, alcohol use, and not taking antacids simultaneously. The label also shows reorder number 111403, lot number L22A81, and expiration date 08/2025.*

FDA Label Image

Figure 1 (Image 01)

A line graph showing mean pain score over eight weeks comparing placebo and Gabapentin 3600 mg/day. The x-axis represents weeks from baseline to week 8, and the y-axis shows mean pain scores from 0 to 10. The graph includes a 4-week dose titration period followed by a 4-week fixed dose period, illustrating decreasing pain scores for Gabapentin compared to placebo.*

FDA Label Image

Figure 2 (Image 02)

Line chart showing mean pain score over a 7-week period for three groups: Placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The baseline and weekly scores are tracked, with a 3-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Figure 3 (Image 03)

A bar chart titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' showing results from two studies. Study 1 compares placebo (PBO) at 12% to GBP 3600 at 29%. Study 2 compares placebo at 14% to GBP 1800 at 32% and GBP 2400 at 34%. Significance levels are indicated by ** (p<0.01) and *** (p<0.001).*

FDA Label Image

Cockcroft And Gault Equation (Image 04)

A mathematical formula table showing the calculation of creatinine clearance (CLCr) based on age, weight, serum creatinine, and a gender adjustment factor for female patients. The formula is used to estimate kidney function.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of gabapentin, showing its molecular arrangement with a cyclohexane ring and attached functional groups including an amino and a carboxyl group.*

FDA Label Image

Image-09 (Image 09)

A scatter plot showing percentage difference on the y-axis against daily dose in milligrams on the x-axis for Gabapentin capsules. The graph compares three studies labeled as Study a, Study b, and Study c, with data points indicating differences at doses of 600, 900, 1200, and 1800 mg.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.